Lucid Diagnostics (LUCD) Total Debt (2021)

Lucid Diagnostics (LUCD) reported Total Debt of $22.4 million for Q3 2021.

Lucid Diagnostics (LUCD) Total Debt (2021) Analysis & Trends

Lucid Diagnostics has reported Total Debt for 1 years, with the latest figure at $22.4 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 34.05 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 14.72 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 28.07 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.48 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.93 Bn
10 Lucid Diagnostics 149.20 Mn 121.33 Mn -325,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2021 22.40 Mn